Home01_Welcome_to_KDH.html01_Welcome_to_KDH.htmlshapeimage_2_link_0
Solutions021_Solutions.html021_Solutions.htmlshapeimage_3_link_0
Investors04_Investors.html04_Investors.htmlshapeimage_4_link_0
News & Events051_News_%26_Events.html051_News_%26_Events.htmlshapeimage_5_link_0
Contact Us014_Contact_Us.html014_Contact_Us.htmlshapeimage_6_link_0

KEY TECHNOLOGIES

Technology Overview031_Technology.html031_Technology.htmlshapeimage_8_link_0
Key Technologiesshapeimage_9_link_0
Employment015_Employment.html015_Employment.htmlshapeimage_10_link_0
Contact Us014_Contact_Us.html014_Contact_Us.htmlshapeimage_11_link_0

KDH has developed information collection and analysis at the point of care that delivers knowledge of patients and their conditions to subscribers from pharmaceutical developers to government health agencies.

The KDH Global Health Network (GHN) provides universal screening and the identification of the high volumes of candidates needed to test more drugs faster for ever more narrowly defined medical conditions.

The GHN is based on KDH's pending patent for a "System and Method for Remote Access, Data Security and Integrity", which constructs a distributed environment of independent and autonomous sites composed of encapsulated, secure, autonomous servers located behind hospital firewalls. These servers use KDH's patent pending Goal Oriented Architectural Language GOAL to process GHN requests according to local conditions, capabilities and constraints without requiring preconfigured workflows. The architecture is more fully described in a document titled, "GOAL Introduction."

Unlike an Enterprise Service Bus, the GHN is inherently secure since communication between our servers is based on the exchange of wrapped data objects without requiring the use of remote service calls; this exchange uses standardized containers that guarantee security and authenticity with a single standard interface for all locations.

Using the GHN creates an experience similar to working with a huge local computer system for accessing and storing information about patients - local and remote. Traditional concepts of "networking" do not come into play as all transactions with the GHN resemble use of local resources.

However, the GHN also supports social networking between researchers and research sites to collaborate in multi-center clinical trials. The GHN can be independently configured to implement local IRB (Institutional Review Board) protocols for patient contact and sharing patient information with remote investigators, reference labs and data management sites for each trial.

Some of the KDH developed technologies employed in the GHN that permit KDH to deploy the GHN in a reasonable timeframe and a surprisingly low implementation cost:

  1. Automated decomposition of tasks eliminates the need for coding and testing a new application for every new clinical trial. The KDH system applies its library of skills to cope with situations as they occur in real time, while completely new requirements can be coded and added incrementally to the skills library.

  2. Publishing of clinical data together with its context eliminates the need to build record locator services or central databases in order to find patients, because it's inherent in the architecture. GHN also aggregates patient information from world-wide sources without the need for a universal syntax and universal vocabulary.

  3. Secure data communication without a requirement for physically secure networks such as VPN or other secure pipes. Medical records are inviting targets, so the GHN and patient data on the GHN are protected even if users' computers are successfully hacked. Ultimately, the GHN will reduce the economic benefit of hacking for fraud and identity theft.

  4. Authenticated point-to-point communication connects thousands of hospitals and eliminates the overhead of a centralized datacenter that can become a choke-point for communication and an easy target for hackers. The GHN also enables each hospital to apply their local patient privacy regulations and respond to the GHN appropriately.

These capabilities enable the KDH business model of providing universal enrollment for clinical trials. KDH has already demonstrated the code required to perform this new approach of connecting users to information without the constraints of geography or of traditional networks.

What makes KDH unique ?

Our Company011_Introduction_to_KDH.html011_Introduction_to_KDH.htmlshapeimage_13_link_0
Technology031_Technology.html031_Technology.htmlshapeimage_14_link_0

CLINICAL PATIENT RECRUITMENT SOLUTIONS

FOR THE 21st CENTURY

CLIENT LOGIN >>08_Client_Login.html08_Client_Login.htmlshapeimage_16_link_0